News & Stories from the Rogel Cancer Center
News Release
ASCO 2026 Rogel Recap
U-M Rogel Cancer Center researchers participated in oral presentations, poster sessions and panel discussions at the 2026 American Society of Clinical Oncology Annual (ASCO) Meeting.
Health Lab
Study explains how colorectal cancer cells maintain high iron levels
How colorectal cancer cells maintain high iron levels, according to Michigan Medicine research.
News Release
Ljungman receives $500K from the Little Warrior Foundation for Ewing sarcoma gene-editing therapy
Mats Ljungman, Ph.D., professor of radiation oncology and environmental health sciences at the University of Michigan, received a $528,728 award from the Little Warrior Foundation to further research using a gene editing system to target a gene fusion involved in Ewing sarcoma.
News Release
2 Rogel members recognized by American Thyroid Association
Megan R. Haymart, M.D., and Maria Papaleontioui, M.D., both received awards from the the American Thyroid Association.
Health Lab
Receiving personalized treatment for a rare neuroendocrine tumor
Danielle Schuldt was diagnosed with a rare endocrine tumor and underwent surgery as part of her treatment. She now undergoes regular surveillance to monitor for cancer recurrence.
Health Lab
Stopping Ewing sarcoma relapses where they start
Research on stopping Ewing sarcoma relapses through Michigan Medicine.
Health Lab
Nanoparticles genetically modify several human cell types
In a demonstration that helps pave the way for gene therapies with fewer side effects, several human cell types were genetically modified with protein nanoparticles designed at University of Michigan Engineering and Michigan Medicine.
Health Lab
Study sheds light on how early pancreas lesions become cancerous
Why many precursor lesions never develop into pancreatic cancer, according to findings from Michigan Medicine.
Health Lab
Phase 1 trial of alrizomadlin shows promise in targeting metastatic salivary gland cancers
University of Michigan researchers, in partnership with Ascentage Pharma, developed a drug known as alrizomadlin, or APG-115, to target metastatic salivary gland cancers.
Health Lab
Urine-based test detects aggressive prostate cancer
Researchers at have validated a previously developed urine test, which can potentially bypass invasive procedures for prostate cancer detection among men who are unlikely to benefit.
Health Lab
New dual-target drug may help overcome immunotherapy resistance in pancreatic cancer
U-M researchers developed a new strategy to improve immunotherapy treatments for pancreatic cancer.
Health Lab
First U-M patient receives newly FDA-approved stem cell therapy for sickle cell anemia
Elijah Dottery, diagnosed with sickle cell anemia as a baby, becomes the first U-M patient to receive the newly-approved FDA therapy which involves using mesenchymal stem cells.
